Trending Stock News

Heathbridge Capital Management LTD Cut By $567,100 Its Disney Walt Co (DIS) Stake; Diplomat Pharmacy, Inc. (DPLO) Had 6 Analysts Last Week

The Walt Disney Company (NYSE:DIS) Logo

Among 15 analysts covering Diplomat Pharmacy (NYSE:DPLO), 6 have Buy rating, 0 Sell and 9 Hold. Therefore 40% are positive. Diplomat Pharmacy had 45 analyst reports since August 4, 2015 according to SRatingsIntel. Robert W. Baird downgraded the shares of DPLO in report on Thursday, November 16 to “Neutral” rating. Robert W. Baird maintained it with “Hold” rating and $22.0 target in Tuesday, February 27 report. The company was maintained on Tuesday, August 8 by Robert W. Baird. The company was maintained on Wednesday, October 21 by Mizuho. The firm has “Buy” rating by Deutsche Bank given on Friday, March 2. The firm has “Buy” rating by UBS given on Wednesday, October 21. On Thursday, November 3 the stock rating was downgraded by Leerink Swann to “Mkt Perform”. The firm has “Market Perform” rating by Cowen & Co given on Thursday, November 3. The company was maintained on Tuesday, February 27 by Leerink Swann. The stock of Diplomat Pharmacy, Inc. (NYSE:DPLO) has “Hold” rating given on Wednesday, January 24 by Mizuho. See Diplomat Pharmacy, Inc. (NYSE:DPLO) latest ratings:

08/03/2018 Broker: Barclays Capital Rating: Overweight New Target: $27 Initiates Coverage On
02/03/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Upgrade
27/02/2018 Broker: Robert W. Baird Rating: Hold New Target: $22.0 Maintain
27/02/2018 Broker: Needham Rating: Buy New Target: $28.0 Maintain
27/02/2018 Broker: Wells Fargo Rating: Market Perform Old Target: $21.5 New Target: $25 Maintain
27/02/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $32 New Target: $30 Maintain
09/02/2018 Broker: Lake Street Rating: Buy New Target: $35 Initiates Coverage On
02/02/2018 Broker: Deutsche Bank Rating: Hold New Target: $29.0 Downgrade
25/01/2018 Broker: Credit Suisse Rating: Hold New Target: $28.0 Upgrade
24/01/2018 Broker: Mizuho Rating: Hold New Target: $25.0 Maintain

Heathbridge Capital Management Ltd decreased Disney Walt Co (DIS) stake by 1.93% reported in 2017Q4 SEC filing. Heathbridge Capital Management Ltd sold 5,300 shares as Disney Walt Co (DIS)’s stock declined 8.57%. The Heathbridge Capital Management Ltd holds 268,750 shares with $28.89 million value, down from 274,050 last quarter. Disney Walt Co now has $150.73 billion valuation. The stock decreased 0.11% or $0.11 during the last trading session, reaching $100.24. About 10.33 million shares traded or 24.60% up from the average. The Walt Disney Company (NYSE:DIS) has declined 11.59% since April 17, 2017 and is downtrending. It has underperformed by 23.14% the S&P500.

Among 39 analysts covering The Walt Disney Company (NYSE:DIS), 24 have Buy rating, 3 Sell and 12 Hold. Therefore 62% are positive. The Walt Disney Company has $144.0 highest and $10.55 lowest target. $116.60’s average target is 16.32% above currents $100.24 stock price. The Walt Disney Company had 153 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned “Mkt Perform” rating on Friday, April 7 by FBR Capital. The firm has “Sell” rating given on Monday, October 16 by BMO Capital Markets. Bernstein downgraded the shares of DIS in report on Thursday, August 20 to “Market Perform” rating. The firm has “Buy” rating by Nomura given on Tuesday, April 26. The stock of The Walt Disney Company (NYSE:DIS) earned “Hold” rating by Deutsche Bank on Thursday, February 18. Morgan Stanley maintained it with “Overweight” rating and $130 target in Thursday, April 20 report. The firm has “Hold” rating given on Tuesday, August 8 by Cowen & Co. Piper Jaffray maintained it with “Buy” rating and $125.0 target in Friday, December 15 report. The firm has “Neutral” rating by Goldman Sachs given on Tuesday, December 15. The rating was maintained by UBS with “Buy” on Monday, December 18.

Since February 26, 2018, it had 0 insider buys, and 1 sale for $194,780 activity. $194,780 worth of The Walt Disney Company (NYSE:DIS) was sold by LEWIS AYLWIN B.

Analysts await The Walt Disney Company (NYSE:DIS) to report earnings on May, 8 after the close. They expect $1.68 earnings per share, up 12.00% or $0.18 from last year’s $1.5 per share. DIS’s profit will be $2.53 billion for 14.92 P/E if the $1.68 EPS becomes a reality. After $1.89 actual earnings per share reported by The Walt Disney Company for the previous quarter, Wall Street now forecasts -11.11% negative EPS growth.

Investors sentiment increased to 0.9 in 2017 Q4. Its up 0.01, from 0.89 in 2017Q3. It improved, as 58 investors sold DIS shares while 690 reduced holdings. 162 funds opened positions while 508 raised stakes. 896.07 million shares or 0.31% less from 898.84 million shares in 2017Q3 were reported. Spf Beheer Bv owns 2.71% invested in The Walt Disney Company (NYSE:DIS) for 602,652 shares. Marshall Wace Llp holds 0.11% of its portfolio in The Walt Disney Company (NYSE:DIS) for 25,397 shares. Birmingham Capital Co Al holds 23,556 shares or 0.97% of its portfolio. Cubic Asset Mgmt Limited Com has invested 1.39% in The Walt Disney Company (NYSE:DIS). Zacks Investment Mngmt reported 0.27% stake. Alps Advsr holds 2,893 shares or 0% of its portfolio. Holt Capital Advsrs Lc Dba Holt Capital Ptnrs LP reported 0.07% of its portfolio in The Walt Disney Company (NYSE:DIS). Sonata Cap Group, Washington-based fund reported 2,232 shares. Creative Planning accumulated 0.11% or 242,644 shares. Howland Capital Management Ltd Liability holds 9,355 shares. The Connecticut-based Hartford has invested 1.73% in The Walt Disney Company (NYSE:DIS). First Personal Service owns 8,305 shares. Vontobel Asset Mngmt reported 2.38M shares or 1.86% of all its holdings. Gamco Invsts Et Al holds 96,583 shares or 0.07% of its portfolio. Grassi Investment Mgmt has 0.9% invested in The Walt Disney Company (NYSE:DIS) for 51,532 shares.

Investors sentiment increased to 1.89 in 2017 Q4. Its up 0.45, from 1.44 in 2017Q3. It is positive, as 17 investors sold Diplomat Pharmacy, Inc. shares while 40 reduced holdings. 45 funds opened positions while 63 raised stakes. 47.12 million shares or 4.65% less from 49.42 million shares in 2017Q3 were reported. Northern Tru Corp owns 1.24 million shares or 0.01% of their US portfolio. 108,089 were reported by Prudential. Meeder Asset Mngmt holds 0% or 43 shares. Louisiana State Employees Retirement holds 0.02% or 20,700 shares. Trexquant L P stated it has 0.04% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Cornerstone Mgmt Hldgs Limited Liability Corporation invested in 192,800 shares or 0.03% of the stock. Jennison Assocs Limited Liability Corporation invested in 15,359 shares or 0% of the stock. State Of Tennessee Treasury Department owns 37,650 shares. 11,109 are owned by Peak6 Ltd Partnership. Price T Rowe Assocs Incorporated Md reported 0% of its portfolio in Diplomat Pharmacy, Inc. (NYSE:DPLO). Wealthtrust has 171 shares. Thrivent For Lutherans has 0% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO). Jefferies Lc holds 0% or 5,800 shares in its portfolio. Paloma Ptnrs Mgmt owns 38,502 shares for 0.01% of their portfolio. 15,193 are owned by First Mercantile Company.

The stock increased 4.60% or $0.89 during the last trading session, reaching $20.25. About 1.08M shares traded or 20.77% up from the average. Diplomat Pharmacy, Inc. (NYSE:DPLO) has risen 34.38% since April 17, 2017 and is uptrending. It has outperformed by 22.83% the S&P500.

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company has market cap of $1.50 billion. The firm stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It has a 88.82 P/E ratio. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems.

Since March 9, 2018, it had 0 insider purchases, and 1 insider sale for $44.40 million activity. Hagerman Philip R sold $44.40 million worth of stock or 2.15 million shares.

Diplomat Pharmacy, Inc. (NYSE:DPLO) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *